Moderna's Shares Reach New Heights Amidst Patent Ruling and Clinical Trial Optimism
Moderna's stock price climbed 10% on Thursday, marking a four-day streak and attaining its highest intraday value since November 2024. Over the past month, shares have surged 57%, significantly surpassing analysts' average price targets. This momentum has been partly attributed to a favorable European patent decision and anticipation surrounding on…